2024 Imu top 20 shareholders

Imu top 20 shareholders

Author: rajx

August undefined, 2024

Witryna21 godz. temu · Price return in CY23 so far: 30%, while in CY22 it has fallen: 53%CMP: Rs 583 52-week high: Rs 803Growth in net profit with increasing profit margin (QoQ)Company with no debtIncreasing profits every quarter for the past 4 quartersIncreasing revenue every quarter for the past 2 quartersFII / FPI or … Witryna27 maj 2024 · Shareholders would probably be interested to learn that insiders own …

IMU (ASX) IMU Top 20 Shareholders = 36% of the total equity

Witryna24 mar 2024 · Current share price for MSB : $0.925 0.01 (1.07%) Mesoblast Limited (MSB), an ASX-listed company, is an Australian company engaged in the development of regenerative medicine products. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental … Top 20 Shareholders About the Data Show All Shareholder Distribution As reported in the most recent Annual Report. Substantial Shareholders No Substantial Shareholders for IMU in our database. Shareholders Buying 12 month transaction history compiled from ASX announcements. christoph hansen mungard

Mesoblast Limited (ASX: MSB) - Intelligent Investor

WitrynaIMU UNATTRACTIVE : Imugene's dividend yield of 0.0% is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. Dividend Yield explained Implied Growth 40.7% 11.7% Industry Avg IMU WitrynaIMU share price and company information for ASX:IMU Refresh Data Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. Index data is provided © S&P Dow Jones Indices LLC 2024. All rights reserved. ABOUT US About ASX ASX shareholders Our Board Corporate governance Sustainability … Witryna31 sty 2024 · Who’s in the top 20? The company’s largest shareholder remains its Founder and Chief Technology Officer, Peter Van Der Made, with 160.3 million shares. This equates to an interest of 9.351% in the company. After Van Der Made, the share registry is dominated by a host of investment banks. gfi heat treating

Prescient Therapeutics Ltd (ASX:PTX) Share Price - Market Index

Imu top 20 shareholders

Imugene Share Price - ASX:IMU Stock Research Stockopedia

Witryna6 sty 2024 · The Imugene Limited ( ASX: IMU) share price is sliding in negative territory today despite a positive company update. At the time of writing, the immuno-oncology company’s shares are down 7.18% trading at 36 cents. It’s worth noting that Imugene shares have extended its losses to around 25% in the past month. Imugene secures …

Did you know?

WitrynaHigh-performance Inertial Measurement Unit (IMU) Market Size & Share Analysis - … WitrynaImugene Limited (IMU.AX) stock major holders – Yahoo Finance ️ Sign up Imugene …

WitrynaTop 20 Shareholders; Shareholder Services; Investor FAQs; US Shareholders; … Witryna10 kwi 2024 · Shareholders of Aldrees Petroleum and Transport Services Co. will vote on a 20% dividend payout, at SAR 2 per share, for 2024 during the extraordinary general meeting (EGM) scheduled for May 1. May 1, 2024 (Shareholders registered with Edaa at the end of the second trading day following the EGM date)

WitrynaHER-Vaxx is a B-cell immuno-therapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. PD1-Vaxx is a B-cell immuno-therapy which aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and thus produce an anticancer effect similar to ... Witryna12 kwi 2024 · Luke Forrestal; Khia Mercer; David Ciampa; Peter Wells; Imugene (IMU) …

Witryna22 mar 2024 · Imugene Limited is an Australia-based clinical-stage immuno-oncology …

WitrynaAmplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer. FAK also plays a … gfi hartland wiWitrynaShareholders > Details - - - Add Simple Chart Technical Chart Intraday Daily Weekly … christoph happelWitrynaA substantial shareholder is a person or entity that owns 5% or more of the voting … gfi headquartersWitryna6 kwi 2024 · Current share price for AVH : $3.930 0.04 (1.01%) AVITA Medical, Inc. (AVH, formerly AVITA Therapeutics, Inc.), an ASX-listed company, is a regenerative medicine group with a technology platform positioned to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics … gfi healthbrewWitryna2 maj 2024 · Imugene shares reached an all-time high of 62.5 cents in November, before shifting to a downhill trend. Based on today’s price, Imugene has a market capitalisation of roughly $1.12 billion with approximately 5.85 billion shares on issue. gfi hive podcastWitrynaShares in Imugene last closed at AU$0.14 and the price had moved by-44% over the … gfi has no powerWitryna11 lut 2024 · Can someone with better research capacity shed some light on the new number 20 share holder:- MR Jeffery Brian Wilton, was doing Google on his name, but only the BRN share holding list come up. Many thx. He could be one of us investors on this forum, as would be many others here who would be in the top 100 shareholders … christoph happe münster